Robert E. George
Director at Moleculin Biotech, Inc. (MBRX)
Robert E. George has filed 6 insider reports with the SEC since June 2022, as director at Moleculin Biotech, Inc. (MBRX). Robert E. George made no open-market purchases or sales in the last 12 months. The latest filing, on November 19, 2026, reports grant or award at Moleculin Biotech, Inc. (MBRX).
- Filings
- 6
- Companies
- 1
- Bought on market
- $10K
- Sold on market
- None
Companies where Robert E. George is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 14,660 | $10K | $0.69 | $7.74+1022% | Nov 19, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Nov 17, 2026MBRXDirector Robert E. George was granted 4,000 stock optionsForm 4Grant or award
- Nov 12, 2025MBRXSEC Form 4 filed by Director George Robert E.Form 4Grant or award
- Nov 4, 2024MBRXSEC Form 4 filed by Director George Robert E.Form 4Grant or award
- Dec 26, 2023+$10KMBRXGeorge Robert E. bought $10,000 worth of shares (14,493 units at $0.69), increasing direct ownership by 8,678% to 14,660 unitsForm 4Open-market purchase
- May 25, 2023MBRXSEC Form 4 filed by George Robert E.Form 4Grant or award
- Jun 20, 2022MBRXSEC Form 4 filed by George Robert E.Form 4Grant or award
Compare Robert E. George with
- Robert E. George vs Elizabeth Cermak1 shared
- Robert E. George vs John M Climaco1 shared
- Robert E. George vs Michael D Cannon1 shared
- Robert E. George vs Jonathan P. Foster1 shared
- Robert E. George vs Walter V Klemp1 shared
- Robert E. George vs Donald H Picker1 shared
Other insiders at the same companies
- Elizabeth CermakMBRX
- John M ClimacoMBRX
- Michael D CannonMBRX
- Jonathan P. FosterMBRX
- Walter V KlempMBRX
- Donald H PickerMBRX
- Joy YanMBRX
Questions about Robert E. George
- What is Robert E. George's role at Moleculin Biotech, Inc.?
- Robert E. George reports to the SEC as director at Moleculin Biotech, Inc. (MBRX), according to the latest filing on November 19, 2026.
- How many shares does Robert E. George own?
- After the latest filing that states it, Robert E. George directly owned 14,660 shares of Moleculin Biotech, Inc. (MBRX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Robert E. George bought or sold stock recently?
- The most recent open-market purchase was on December 26, 2023: bought 14,493 shares of Moleculin Biotech, Inc. (MBRX) for $10K at an average of $0.69.
- How do I get alerts when Robert E. George files?
- Follow Robert E. George on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Robert E. George filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Robert E. George (SEC CIK 0001674701). Totals count each trade once, skipping amendments whose original is on file, from Jun 22, 2022 on. View on SEC EDGAR · Get this as JSON